TRASTUZUMAB BIOSIMILARS MARKET ANALYSIS, 2024

Trastuzumab, a monoclonal antibody used in the treatment of HER2-positive breast cancer, has revolutionized cancer care by targeting the HER2 receptor, which is overexpressed in some breast cancer cases. As the demand for more affordable treatments increases, trastuzumab biosimilars have become an essential solution, improving access to critical th